Abstract
This supplement on evaluating CD4 diagnostics for HIV is the fourth in a series of user-friendly operational guides explaining how to conduct evaluations of diagnostic tests for infectious diseases that are of public health importance in the developing world. Here, Andrew Redd and Thomas Quinn introduce the supplement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hogg, R. S. et al. JAMA 286, 2568–2577 (2001).
Palella, F. J. Jr, . et al. Ann. Intern. Med. 138, 620–626 (2003).
Hallett, T. B., Gregson, S., Dube, S. & Garnett, G. P. PLoS Med. 5, e53 (2008).
Schreibman, T. & Friedland, G. Clin. Infect. Dis. 38, 257–262 (2004).
HIV Paediatric Prognostic Markers Collaborative Study. Lancet 366, 1868–1874 (2005).
Spacek, L. A., Griswold, M., Quinn, T. C. & Moore, R. D. AIDS 17, 1311–1317 (2003).
Kamya, M. R. et al. Afr. Health Sci. 4, 94–101 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Redd, A., Quinn, T. CD4 immunodiagnostics for HIV in the developing world. Nat Rev Microbiol 6 (Suppl 11), S1 (2008). https://doi.org/10.1038/nrmicro1996
Issue date:
DOI: https://doi.org/10.1038/nrmicro1996